Polyclonal light chains in cerebrovascular disease

Patrizia Fiori1, Maria Giannetti Luigi2, Linda Iurato1, Carminantonio Tammaro3, Gigliola Esposito3, Antonio Monaco11Central Operative Unit of Neurology (Dir. A Monaco), 2Infantile Neuropsychiatry and Social Service (Dir. LM Giannetti), 3Laboratory (Dir. CA Tammaro), ASL AV, Civil Hospital of Ariano...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Patrizia Fiori, Maria Giannetti Luigi, Linda Iurato, et al
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2010
Materias:
Acceso en línea:https://doaj.org/article/33c4d09d9299432e96a6e6264711905e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:33c4d09d9299432e96a6e6264711905e
record_format dspace
spelling oai:doaj.org-article:33c4d09d9299432e96a6e6264711905e2021-12-02T05:54:22ZPolyclonal light chains in cerebrovascular disease1176-63281178-2021https://doaj.org/article/33c4d09d9299432e96a6e6264711905e2010-08-01T00:00:00Zhttp://www.dovepress.com/polyclonal-light-chains-in-cerebrovascular-disease-a5099https://doaj.org/toc/1176-6328https://doaj.org/toc/1178-2021Patrizia Fiori1, Maria Giannetti Luigi2, Linda Iurato1, Carminantonio Tammaro3, Gigliola Esposito3, Antonio Monaco11Central Operative Unit of Neurology (Dir. A Monaco), 2Infantile Neuropsychiatry and Social Service (Dir. LM Giannetti), 3Laboratory (Dir. CA Tammaro), ASL AV, Civil Hospital of Ariano Irpino, University of Naples, ItalyAbstract: Altered membrane permeability is a hallmark of inflammation and ischemia with systemic spreading. Renal dysfunction is a risk factor for cardiovascular, cerebrovascular, and metabolic diseases. The aim of the present study was to assess proteinuria and urinary polyclonal light chains in acute stroke and chronic cerebrovascular disease compared with other neurologic diseases. Our results showed significantly increased levels of urinary polyclonal light chains in cerebrovascular disease compared with other neurologic diseases. The highest values of urinary polyclonal κ chains were found in acute stroke compared with chronic cerebrovascular disease and other neurologic diseases, while the level of λ chains was mainly increased in chronic cerebrovascular diseases. The shift to chronic renal failure seems to be signaled by a decreased polyclonal light chain/creatinemia ratio. The absence of a significant correlation with blood pressure and other seric parameters suggests that polyclonal light chains are an early marker of reversible vascular impairment with renal dysfunction before progression to irreversible renal failure and need for dialysis and/or intensive care.Keywords: polyclonal light chains, cerebrovascular disease, renal failure Patrizia FioriMaria Giannetti LuigiLinda Iuratoet alDove Medical PressarticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2010, Iss Issue 1, Pp 533-537 (2010)
institution DOAJ
collection DOAJ
language EN
topic Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Patrizia Fiori
Maria Giannetti Luigi
Linda Iurato
et al
Polyclonal light chains in cerebrovascular disease
description Patrizia Fiori1, Maria Giannetti Luigi2, Linda Iurato1, Carminantonio Tammaro3, Gigliola Esposito3, Antonio Monaco11Central Operative Unit of Neurology (Dir. A Monaco), 2Infantile Neuropsychiatry and Social Service (Dir. LM Giannetti), 3Laboratory (Dir. CA Tammaro), ASL AV, Civil Hospital of Ariano Irpino, University of Naples, ItalyAbstract: Altered membrane permeability is a hallmark of inflammation and ischemia with systemic spreading. Renal dysfunction is a risk factor for cardiovascular, cerebrovascular, and metabolic diseases. The aim of the present study was to assess proteinuria and urinary polyclonal light chains in acute stroke and chronic cerebrovascular disease compared with other neurologic diseases. Our results showed significantly increased levels of urinary polyclonal light chains in cerebrovascular disease compared with other neurologic diseases. The highest values of urinary polyclonal κ chains were found in acute stroke compared with chronic cerebrovascular disease and other neurologic diseases, while the level of λ chains was mainly increased in chronic cerebrovascular diseases. The shift to chronic renal failure seems to be signaled by a decreased polyclonal light chain/creatinemia ratio. The absence of a significant correlation with blood pressure and other seric parameters suggests that polyclonal light chains are an early marker of reversible vascular impairment with renal dysfunction before progression to irreversible renal failure and need for dialysis and/or intensive care.Keywords: polyclonal light chains, cerebrovascular disease, renal failure
format article
author Patrizia Fiori
Maria Giannetti Luigi
Linda Iurato
et al
author_facet Patrizia Fiori
Maria Giannetti Luigi
Linda Iurato
et al
author_sort Patrizia Fiori
title Polyclonal light chains in cerebrovascular disease
title_short Polyclonal light chains in cerebrovascular disease
title_full Polyclonal light chains in cerebrovascular disease
title_fullStr Polyclonal light chains in cerebrovascular disease
title_full_unstemmed Polyclonal light chains in cerebrovascular disease
title_sort polyclonal light chains in cerebrovascular disease
publisher Dove Medical Press
publishDate 2010
url https://doaj.org/article/33c4d09d9299432e96a6e6264711905e
work_keys_str_mv AT patriziafiori polyclonallightchainsincerebrovasculardisease
AT mariagiannettiluigi polyclonallightchainsincerebrovasculardisease
AT lindaiurato polyclonallightchainsincerebrovasculardisease
AT etal polyclonallightchainsincerebrovasculardisease
_version_ 1718400164164534272